Warnaar SO - Search Results

1

Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.

Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO, Litvinov SV. Velders MP, et al. Among authors: warnaar so. Cancer Res. 1995 Oct 1;55(19):4398-403. Cancer Res. 1995. PMID: 7671252

2

New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.

Velders MP, Litvinov SV, Warnaar SO, Gorter A, Fleuren GJ, Zurawski VR Jr, Coney LR. Velders MP, et al. Among authors: warnaar so. Cancer Res. 1994 Apr 1;54(7):1753-9. Cancer Res. 1994. PMID: 8137290

3

Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.

van Dijk J, Uemura H, Beniers AJ, Peelen WP, Zegveld ST, Fleuren GJ, Warnaar SO, Oosterwijk E. van Dijk J, et al. Among authors: warnaar so. Int J Cancer. 1994 Jan 15;56(2):262-8. doi: 10.1002/ijc.2910560220. Int J Cancer. 1994. PMID: 8314310

4

Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3.

van Ravenswaay Claasen HH, van de Griend RJ, Mezzanzanica D, Bolhuis RL, Warnaar SO, Fleuren GJ. van Ravenswaay Claasen HH, et al. Among authors: warnaar so. Int J Cancer. 1993 Aug 19;55(1):128-36. doi: 10.1002/ijc.2910550123. Int J Cancer. 1993. PMID: 8344744

5

Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.

Luiten RM, Coney LR, Fleuren GJ, Warnaar SO, Litvinov SV. Luiten RM, et al. Among authors: warnaar so. Br J Cancer. 1996 Sep;74(5):735-44. doi: 10.1038/bjc.1996.430. Br J Cancer. 1996. PMID: 8795576 Free PMC article.

6

The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease.

Velders MP, van Rhijn CM, Cornelissen IM, van Muijen GN, Briaire IH, Dohlsten M, Fleuren GJ, Warnaar SO, Litvinov SV. Velders MP, et al. Among authors: warnaar so. J Immunother Emphasis Tumor Immunol. 1996 Jul;19(4):245-56. doi: 10.1097/00002371-199607000-00001. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8877719

7

The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.

Velders MP, van Rhijn CM, Oskam E, Fleuren GJ, Warnaar SO, Litvinov SV. Velders MP, et al. Among authors: warnaar so. Br J Cancer. 1998 Aug;78(4):478-83. doi: 10.1038/bjc.1998.518. Br J Cancer. 1998. PMID: 9716030 Free PMC article.

8

Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.

van Dijk J, Warnaar SO, van Eendenburg JD, Thienpont M, Braakman E, Boot JH, Fleuren GJ, Bolhuis RL. van Dijk J, et al. Among authors: warnaar so. Int J Cancer. 1989 Feb 15;43(2):344-9. doi: 10.1002/ijc.2910430230. Int J Cancer. 1989. PMID: 2521843

9

Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity.

van Dijk J, Zegveld ST, Fleuren GJ, Warnaar SO. van Dijk J, et al. Among authors: warnaar so. Int J Cancer. 1991 Jul 9;48(5):738-43. doi: 10.1002/ijc.2910480518. Int J Cancer. 1991. PMID: 1830033

10

Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.

Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Litvinov SV, et al. Among authors: warnaar so. Cell Adhes Commun. 1994 Oct;2(5):417-28. doi: 10.3109/15419069409004452. Cell Adhes Commun. 1994. PMID: 7842256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters